Addenbrooke’s Cognitive Examination-III (ACE-III), a well-established cognitive screening tool, has been standardized and validated for use across seven Indian languages to diagnose dementia with high accuracy.
Adapted versions of Addenbrooke's Cognitive Examination (ACE-III) have been standardized and validated for use across seven Indian languages, with high diagnostic accuracy in identifying dementia and MCI in a linguistically diverse context, reports a new study. The findings of the study are published in the journal Archives of Clinical Neuropsychology.// A standardized test that can now be used in the seven main languages in India will support the diagnosis of dementia and mild cognitive impairment.
‘With the rising burden of dementia globally, there is a need to harmonize dementia research across diverse populations. Hence, researchers have adapted ACE-III, a well-known screening instrument for dementia detection/diagnosis, to be used in Hindi, Telugu, Kannada, Malayalam, Urdu, Tamil, and Indian English.
’
Read More..
The work was carried out by the University of East Anglia (UEA) in the UK and in India at the National Institute of Mental Health and Neurosciences (NIMHANS) and Manipal Hospitals, Bengaluru; Nizam's Institute of Medical Sciences, Hyderabad; Shree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum; All India Institute of Medical Sciences, Delhi; and Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. Read More..
The study, 'Dementia diagnosis in seven languages: the Addenbrooke's Cognitive Examination-III in India,' is published in the Archives of Clinical Neuropsychology.
Prof Suvarna Alladi, professor of neurology at NIMHANS in Bengaluru, was the lead researcher.
"The ACE-III is a well-established cognitive screening tool to diagnose dementia, but there have been few efforts to standardize the use of it across cohorts speaking different languages. We aimed to standardize and validate ACE-III across seven Indian languages, and to assess the diagnostic accuracy of the test to detect dementia and mild cognitive impairment."
The researchers said a major proportion - 58 percent - of people with dementia reside in low- and middle-income countries, and by 2050 that will increase to 68 percent. Therefore, standardizing diagnostic tools for dementia is important to accurately determine prevalence rates and to establish risk and protective factors for dementia.
Advertisement
In accordance with the original version of ACE-III, the Indian versions look at five different cognitive functions: attention; memory; fluency; language; and visuospatial functions.
Advertisement
A common administration and scoring guide was developed, and psychologists were trained to ensure standardized test assessment in seven Indian languages.
Prof Eneida Mioshi, professor of dementia care research at UEA's School of Health Sciences, said: "Accounting for cultural differences and linguistic characteristics of different populations is crucial for the development of a common instrument to diagnose dementia.
"The development of a common diagnostic tool will facilitate harmonization of dementia research across diverse populations, and catalyze the development of preventative and treatment strategies for larger cohorts of dementia from diverse demographic and geographic backgrounds."
ACE-III had previously been adapted and validated into one of the Indian languages - Gujarati. Additionally, the ACE-III tool has been validated in languages including Arabic, English, French, German, Greek, Hebrew, Italian, Japanese, Korean, Mandarin, Portuguese, Spanish and others.
Prof Mioshi said: "The adapted versions of ACE-III show great diagnostic accuracy in identifying dementia and mild cognitive impairment in a linguistically diverse context. Not only the ACE-III is a quick and inexpensive method of screening for dementia, but it will also allow for harmonization in future cross-national research studies, propelling Indian dementia research forward."
Prof Alladi said: "This adapted version of ACE-III can be used to uniformly diagnose cognitive impairment in people speaking different languages from both rural and urban populations located across India."
Source-Eurekalert